iRhythm Technologies (IRTC) Expected to Announce Quarterly Earnings on Thursday

iRhythm Technologies (NASDAQ:IRTC) is projected to announce its Q1 2025 earnings results after the market closes on Thursday, May 1st. Analysts expect the company to announce earnings of ($0.89) per share and revenue of $153.39 million for the quarter.

iRhythm Technologies (NASDAQ:IRTC) last issued its earnings results on Thursday, February 20th. The company reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.29) by $0.30. The business had revenue of $164.33 million during the quarter, compared to analysts’ expectations of $158.30 million. iRhythm Technologies had a negative return on equity of 118.83% and a negative net margin of 19.14%. On average, analysts expect iRhythm Technologies to post $-2 EPS for the current fiscal year and $-1 EPS for the next fiscal year.

iRhythm Technologies Stock Performance

Shares of iRhythm Technologies stock opened at $106.64 on Tuesday. The stock has a market cap of $3.40 billion, a PE ratio of -29.30 and a beta of 1.45. The business has a fifty day simple moving average of $104.35 and a 200-day simple moving average of $95.44. The company has a quick ratio of 6.12, a current ratio of 6.27 and a debt-to-equity ratio of 9.00. iRhythm Technologies has a 12 month low of $55.92 and a 12 month high of $128.52.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on the company. Oppenheimer raised their target price on iRhythm Technologies from $105.00 to $120.00 and gave the stock an “outperform” rating in a research report on Wednesday, January 8th. Wells Fargo & Company raised their target price on iRhythm Technologies from $86.00 to $104.00 and gave the stock an “equal weight” rating in a research report on Friday, February 21st. Truist Financial raised their target price on iRhythm Technologies from $111.00 to $145.00 and gave the stock a “buy” rating in a research report on Friday, February 21st. Needham & Company LLC raised their target price on iRhythm Technologies from $125.00 to $138.00 and gave the stock a “buy” rating in a research report on Friday, February 21st. Finally, StockNews.com raised iRhythm Technologies from a “sell” rating to a “hold” rating in a research report on Monday, February 24th. Three equities research analysts have rated the stock with a hold rating and nine have given a buy rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $119.73.

About iRhythm Technologies

iRhythm Technologies, Inc, a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services.